Boston Scientific Corp (BSX)

Current ratio

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Total current assets US$ in thousands 6,920,000 8,761,000 8,991,000 8,185,000 6,514,000 6,504,000 5,886,000 5,704,000 5,760,000 5,144,000 5,083,000 5,065,000 6,317,000 6,229,000 6,758,000 6,101,000 6,694,000 6,160,000 5,803,000 4,823,000
Total current liabilities US$ in thousands 6,399,000 5,910,000 5,576,000 4,916,000 4,933,000 4,579,000 4,562,000 4,083,000 3,803,000 3,549,000 3,883,000 4,275,000 4,274,000 4,022,000 4,073,000 3,393,000 3,681,000 3,302,000 3,108,000 3,976,000
Current ratio 1.08 1.48 1.61 1.66 1.32 1.42 1.29 1.40 1.51 1.45 1.31 1.18 1.48 1.55 1.66 1.80 1.82 1.87 1.87 1.21

December 31, 2024 calculation

Current ratio = Total current assets ÷ Total current liabilities
= $6,920,000K ÷ $6,399,000K
= 1.08

The current ratio of Boston Scientific Corp has shown fluctuations over the past few years, ranging from a low of 1.08 to a high of 1.87. The current ratio measures the company's ability to cover its short-term liabilities with its short-term assets. A ratio above 1 indicates the company has more current assets than current liabilities, which is generally considered a positive sign.

Boston Scientific Corp's current ratio dipped to its lowest point of 1.08 on December 31, 2024, which may indicate a potential liquidity challenge during that period. However, the company managed to improve its current ratio in the following quarters, reaching 1.66 on March 31, 2024, suggesting a stronger liquidity position.

Overall, the current ratio of Boston Scientific Corp has exhibited some volatility but generally remained above 1, reflecting the company's ability to meet its short-term obligations with its current assets. It is important for investors and stakeholders to monitor the trend of the current ratio over time to assess the company's liquidity and financial health.


See also:

Boston Scientific Corp Current Ratio (Quarterly Data)